Henan Taloph Pharmaceutical Stock Co Ltd
SSE:600222

Watchlist Manager
Henan Taloph Pharmaceutical Stock Co Ltd Logo
Henan Taloph Pharmaceutical Stock Co Ltd
SSE:600222
Watchlist
Price: 6.58 CNY -1.2% Market Closed
Market Cap: 3.8B CNY

Intrinsic Value

The intrinsic value of one Henan Taloph Pharmaceutical Stock Co Ltd stock under the Base Case scenario is 4.23 CNY. Compared to the current market price of 6.58 CNY, Henan Taloph Pharmaceutical Stock Co Ltd is Overvalued by 36%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
4.23 CNY
Overvaluation 36%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Henan Taloph Pharmaceutical Stock Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Henan Taloph Pharmaceutical Stock Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Henan Taloph Pharmaceutical Stock Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Henan Taloph Pharmaceutical Stock Co Ltd.

Explain Valuation
Compare Henan Taloph Pharmaceutical Stock Co Ltd to

Fundamental Analysis

Henan Taloph Pharmaceutical Stock Co Ltd
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Henan Taloph Pharmaceutical Stock Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Henan Taloph Pharmaceutical Stock Co Ltd

Current Assets 2.2B
Receivables 1.3B
Other Current Assets 936m
Non-Current Assets 1.5B
Long-Term Investments 509m
PP&E 483m
Intangibles 364m
Other Non-Current Assets 183m
Current Liabilities 1.9B
Accounts Payable 343m
Accrued Liabilities 6.5m
Short-Term Debt 639m
Other Current Liabilities 914.5m
Non-Current Liabilities 242m
Long-Term Debt 163m
Other Non-Current Liabilities 79m
Efficiency

Free Cash Flow Analysis
Henan Taloph Pharmaceutical Stock Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Henan Taloph Pharmaceutical Stock Co Ltd

Revenue
1.8B CNY
Cost of Revenue
-1.4B CNY
Gross Profit
419.2m CNY
Operating Expenses
-320.7m CNY
Operating Income
98.5m CNY
Other Expenses
-51.5m CNY
Net Income
47m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Henan Taloph Pharmaceutical Stock Co Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
ROIC is Increasing
Healthy Gross Margin
Sustainable 3Y Average Gross Margin
45/100
Profitability
Score

Henan Taloph Pharmaceutical Stock Co Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Henan Taloph Pharmaceutical Stock Co Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
53/100
Solvency
Score

Henan Taloph Pharmaceutical Stock Co Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Henan Taloph Pharmaceutical Stock Co Ltd

There are no price targets for Henan Taloph Pharmaceutical Stock Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Henan Taloph Pharmaceutical Stock Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Henan Taloph Pharmaceutical Stock Co Ltd stock?

The intrinsic value of one Henan Taloph Pharmaceutical Stock Co Ltd stock under the Base Case scenario is 4.23 CNY.

Is Henan Taloph Pharmaceutical Stock Co Ltd stock undervalued or overvalued?

Compared to the current market price of 6.58 CNY, Henan Taloph Pharmaceutical Stock Co Ltd is Overvalued by 36%.

Back to Top